BiotechTube
Home/Allecra Therapeutics/Adam Belley, PhD
AB

Adam Belley, PhD

Head, R&D

Allecra Therapeutics

Therapeutic Areas

Infectious Disease

Allecra Therapeutics Pipeline

DrugIndicationPhase
Cefepime/EnmetazobactamComplicated Urinary Tract Infections (cUTI)Phase 3

Leadership Team at Allecra Therapeutics

AK
Andreas Kranzusch
Chief Financial Officer
PV
Patrick Velicitat, MD
Chief Medical Officer
OL
Omar Lahlou, PhD
Head, Regulatory Affairs
View full Allecra Therapeutics profile